Amarin Profit Margin

The latest profit margin for AMRN is -17.67% as of June 2026. That compares with -54.01% in the prior-year period — up 67.3% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Amarin's historical trend and sector peers before judging valuation or financial health.

Over the past year, AMRN's profit margin moved from -54.01% to -17.67% — a 67.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Amarin's valuation or profitability profile.

Against Healthcare companies, AMRN currently prints -17.67% for profit margin, while the sector average sits near 14.34%. That is roughly 223.2% below the sector mean. Large gaps often invite a closer look at Amarin's growth, margins, and balance sheet.

Profit Margin shows how effectively Amarin converts resources into returns. At -17.67%, AMRN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -54.01% in the prior-year period — up 67.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting AMRN's profit margin (-17.67%), review year-over-year change from -54.01%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.